Cargando…
Bleomycin-Induced Lung Toxicity in Hodgkin's Lymphoma: Risk Factors in the Positron Emission Tomography Era
Introduction Bleomycin is a major antimitotic agent in the first-line treatment for Hodgkin's lymphoma. The main limitation of its use is its pulmonary toxicity. The objectives of this study are to find out the risk factors for the occurrence of bleomycin-induced lung toxicity in patients with...
Autores principales: | Jennane, Selim, Ababou, Mounir, El Haddad, Mariyam, Ait Sahel, Omar, Mahtat, El Mehdi, El Maaroufi, Hicham, Doudouh, Abderrahim, Doghmi, Kamal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994685/ https://www.ncbi.nlm.nih.gov/pubmed/35419251 http://dx.doi.org/10.7759/cureus.23993 |
Ejemplares similares
-
Posterior Reversible Encephalopathy Syndrome Secondary to R-CHOP Chemotherapy Regimen
por: Jennane, Selim, et al.
Publicado: (2022) -
Acute Laryngeal Dyspnea as the First Presentation of Mantle Cell Lymphoma: A Case Report and Review of the Literature
por: Ababou, Mounir, et al.
Publicado: (2020) -
L’érythroblastopénie et la myélofibrose primitive: association très rare (à propos d’un cas)
por: EL Maachi, Nora, et al.
Publicado: (2022) -
PB2362: THE EFFECT OF BODY MASS INDEX (BMI) ON THE PROGNOSIS OF DLBCL PATIENTS TREATED WITH R-CHOP: A REAL WORLD MOROCCAN EXPERIENCE
por: el Filali, Imane Ait, et al.
Publicado: (2023) -
Prise en charge des syndromes myélodysplasiques au Maroc à propos d´une étude mono-centrique
por: Maaroufi, Hicham El, et al.
Publicado: (2020)